This assay is indicated for the serial measurement of CA 19-9 to aid in the management of patients diagnosed with cancers of the exocrine pancreas.
The test is useful as an aid in monitoring disease status in confirmed pancreatic cancer patients who have had previous elevated levels of serum CA 19-9 at some point in their disease process.
1 yellow-top SST tube (minimum: 0.5 mL of serum). Centrifuge SST 30 minutes after draw. Refrigerate specimen after collection.
Days Set Up: Tuesday, Thursday, Saturday